Loading...
Market
What will be the final acquisition price for Sanofi's consumer health unit by CD&R?
2
Resolution / Starting Odds
Less than €15 billion • 25%
€15 billion to €15.5 billion • 25%
€15.5 billion to €16 billion • 25%
More than €16 billion • 25%
Official announcement from CD&R or Sanofi, financial news outlets
Story
CD&R Nears €15.5 Billion Deal for Sanofi's Consumer Health Unit
Oct 10, 2024, 08:15 PM
CD&R is nearing a significant deal to acquire Sanofi's consumer health unit for approximately €15 billion. The deal, which is close to being finalized, sees CD&R beating out rivals in the pursuit of the unit, which is valued at €15.5 billion. This acquisition is a critical move in the landscape of large leveraged buyouts (LBOs) and serves as a health check for the Sanofi sale.
View original story
Similar markets
Completed • 25%
Delayed • 25%
Cancelled • 25%
Renegotiated • 25%
Yes • 50%
No • 50%
€1.3B or less • 25%
More than €1.3B to €1.5B • 25%
More than €1.5B to €1.7B • 25%
More than €1.7B • 25%
Less than £10 billion • 25%
£10 billion to £12.5 billion • 25%
£12.5 billion to £15 billion • 25%
More than £15 billion • 25%
Johnson & Johnson • 25%
Pfizer • 25%
GlaxoSmithKline • 25%
Other • 25%
Yes • 50%
No • 50%
Less than €50 billion • 25%
€50 billion to €75 billion • 25%
€75 billion to €100 billion • 25%
More than €100 billion • 25%
Less than $500 million • 25%
$500 million - $1 billion • 25%
$1 billion - $2 billion • 25%
More than $2 billion • 25%
Completed Sale • 25%
Talks Abandoned • 25%
Ongoing Negotiations • 25%
Other Outcome • 25%
Less than $27 million • 25%
$27 million to $30 million • 25%
$30 million to $35 million • 25%
More than $35 million • 25%